Special Notice-GSA IDIQ w-Non-GSA items_75F40126Q132815.pdf
PDF 92 KB Posted
- Solicitation number
- 75F40126Q132815
About this file
This is a Special Notice issued by the U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services, announcing the intent to incorporate non-Federal Supply Schedule (FSS) open-market items into a single-award Blanket Purchase Agreement (BPA). The BPA, solicitation number 75F40126Q132815, is targeted to Agilent Technologies, Inc., with an estimated total maximum value of $9.6 million and will be procured using GSA Federal Supply Schedule procedures. The notice satisfies the requirement to synopsize incidental non-Schedule components exceeding $25,000 as mandated by FAR 5.101(a)(1). The classification code is 6640 (Laboratory Equipment and Supplies) and the NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing).
The Government intends to incorporate open-market components valued at $103,374.42 directly into the final BPA structure. These components include a Software House International (SHI) custom-configured computer workstation; Agilent 1290 Infinity III Fluorescence Detector with 2µL flow cell and installation; Agilent OpenLab CDS Workstation Plus Software with core configuration, instrument connectivity licensing, installation, and one-year software maintenance; Agilent InfinityLab Waste Can and Port Cap Assembly (6-liter container with 4-port safety cap); Agilent InfinityLab Preventive Maintenance Kit configured for the 1290 Multisampler; Agilent 8890/60 Transfer Line Interface Accessory with heated interface, installation, and introduction; and Agilent Headspace Control Software with installation and introduction. The Contracting Officer will conduct a formal price reasonableness determination based on competitive commercial market analyses. All non-Schedule items will be explicitly labeled as individual open-market line items upon final award. Inquiries should be directed to Contracting Officer Suzanne Martella at suzanne.martella@fda.hhs.gov no later than July 24, 2026, at 2:00 PM Central time. This is a Special Notice for information and transparency purposes only and does not constitute a request for competitive quotations.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
SPECIAL NOTICE: NOTICE OF INTENT TO INCORPORATE NON-FSS (OPEN
MARKET) ITEMS OVER $25k ON GSA ORDER
Solicitation/BPA Number: 75F40126Q132815 Target Awardee: Agilent Technologies, Inc.
Classification Code: 6640 – Laboratory Equipment and Supplies NAICS Code: 334516 – Analytical Laboratory Instrument Manufacturing
The purpose of this notification is to meet the requirement to synopsize contract actions expected to exceed $25,000 in accordance with RFO FAR 5.101(a)(1).
1. Notice Purpose and Authority
The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), hereby issues this Special Notice in accordance with RFO Federal Acquisition Regulation (FAR) 8.401. The Government intends to establish a single-award Blanket Purchase Agreement (BPA) with an estimated total maximum value of $9.6 Million utilizing GSA Federal Supply Schedule procurement procedures. This public notice satisfies the statutory requirement to synopsize the incidental, non-Schedule components exceeding $25,000.00 that are anticipated for incorporation into the upcoming competitive BPA solicitation framework.
2. Disclosure of Non-FSS (Open Market) Components
To deliver a turn-key instrumentation framework that satisfies the FDA’s mission requirement, the Government intends to incorporate a subset of Open Market (Non-FSS) components estimated valued at $103,374.42 directly into the final BPA structure.
The specific open-market components to be incorporated include:
• Software House International (SHI) computer workstation, custom-configured for this application
• Agilent 1290 Infinity III Fluorescence Detector (Including 2uL flow cell and installation)
• Agilent OpenLab CDS Workstation Plus Software (Including core configuration, instrument connectivity licensing, installation, and 1-year software maintenance)
• Agilent InfinityLab Waste Can and Port Cap Assembly (6-liter container with 4-port safety cap for laboratory waste management)
• Agilent InfinityLab Preventive Maintenance Kit (Specifically configured for the 1290 Multisampler)
• Agilent 8890/60 Transfer Line Interface Accessory (Including heated interface, installation, and introduction)
• Agilent Headspace Control Software (Including installation and introduction)
In compliance with the streamlined procurement regulations governing the incorporation of non- Schedule items within a Federal Supply Schedule framework under FAR RFO 8.401 and GSAR Subpart 538.71, the Contracting Officer provides the following public disclosures:
• Full Regulatory Compliance: All applicable acquisition regulations pertaining to the purchase of commercial items not on a Federal Supply Schedule are being strictly followed for this component subset, including the public synopsis requirements of FAR RFO 5.101(a)(1) and commercial contracting methods under FAR Part 12.
• Price Determination: A formal determination of price reasonableness for these specific non-Schedule line items will be independently evaluated, verified, and certified by the Contracting Officer prior to final contract execution based on competitive commercial market analyses.
• Sourcing Procurement Labeling: All non-Schedule items will be clearly and explicitly labeled as individual open-market line items upon final award, and all mandatory commercial contract clauses applicable to open-market supplies will be incorporated into the final order.
3. Administrative Instructions
This is a Special Notice published for information and transparency purposes only. This announcement does not constitute a request for competitive open-market quotations, and a separate open-market solicitation will not be issued.
Interested parties possessing inquiries regarding this notice may contact the Contracting Officer, Suzanne Martella, via email at suzanne.martella@fda.hhs.gov no later than 07/24/2026 at 2:00 PM Central time.
mailto:suzanne.martella@fda.hhs.gov
File details come from the government source that posted it. Updated .